Cohen Shawn M, Alexander Ryan S, Holt Stephen R
Program in Addiction Medicine, Section of General Internal Medicine, Yale School of Medicine, 367 Cedar Street, Harkness Hal A, Suite 417A, New Haven, CT 06510, USA.
Program in Addiction Medicine, Section of General Internal Medicine, Yale School of Medicine, 367 Cedar Street, Harkness Hal A, Suite 417A, New Haven, CT 06510, USA; Department of Preventive Medicine, Griffin Hospital, Derby, CT 06418, USA; Department of Internal Medicine, Griffin Hospital, Derby, CT 06418, USA.
Med Clin North Am. 2022 Jan;106(1):43-60. doi: 10.1016/j.mcna.2021.08.003.
In the United States, alcohol is the most common substance used and the spectrum of unhealthy alcohol use is highly prevalent. Complications of unhealthy alcohol use affect nearly every organ system. One of the most frequent and potentially life-threatening of these complications is alcohol withdrawal syndrome for which benzodiazepines remain first-line therapy. Pharmacologic treatment of alcohol use disorder, the most severe form of unhealthy alcohol use, is underutilized despite the availability of multiple effective medications. Although behavioral therapies are an important component of treatment, they are overemphasized at the expense of pharmacotherapy.
在美国,酒精是最常用的物质,不健康饮酒的情况极为普遍。不健康饮酒的并发症几乎会影响到每个器官系统。这些并发症中最常见且可能危及生命的一种是酒精戒断综合征,苯二氮䓬类药物仍是其一线治疗药物。尽管有多种有效的药物,但酒精使用障碍(不健康饮酒最严重的形式)的药物治疗仍未得到充分利用。虽然行为疗法是治疗的重要组成部分,但却被过度强调,而牺牲了药物治疗。